Neurocrine Biosciences, Inc. (NBIX)
130.00
+1.62
(+1.26%)
USD |
NASDAQ |
Feb 24, 09:33
Neurocrine Biosciences Price : 130.00 for Feb. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Glaukos Corp. | 120.99 |
| Edgewise Therapeutics, Inc. | 30.62 |
| Nuvalent, Inc. | 104.37 |
| Marker Therapeutics, Inc. | 1.47 |
| CapsoVision, Inc. | 5.35 |
Price Related Metrics
| PE Ratio | 27.85 |
| PS Ratio | 4.655 |
| PEG Ratio | 0.6658 |
| Price to Book Value | 4.011 |
| Price to Free Cash Flow | 17.78 |
| Earnings Yield | 3.59% |
| Market Cap | 13.05B |
| PEGY Ratio | 0.6658 |
| Operating PE Ratio | 20.92 |
| Normalized PE Ratio | 27.01 |